Finding the ‘Guilty’ Gene Variant of Sporadic Parkinson’s Disease Via CRISPR/Cas9

被引:0
|
作者
Shenzhao Lu
Jiawei Zhou
机构
[1] Chinese Academy of Sciences,Institute of Neuroscience, State Key Laboratory of Neuroscience, Shanghai Institutes for Biological Sciences
来源
Neuroscience Bulletin | 2017年 / 33卷
关键词
Parkinson’s disease; Genetic variant; CRISPR/Cas9;
D O I
暂无
中图分类号
学科分类号
摘要
Parkinson’s disease (PD) is a common neurodegenerative disorder affecting millions of people worldwide, but its cause and pathogenesis are still not fully understood. Earlier studies have shown that SNCA, which encodes α-synuclein, is one of the key genes associated with PD. Single-nucleotide polymorphism (SNP) variants of SNCA are thought to be correlated with disease onset. The underlying mechanisms however are enigmatic. A recent study published in Nature revealed that one of the SNP variants in the SNCA non-coding element elevated α-synuclein expression in human neurons by reducing the binding efficiency of transcription factors, demonstrating a previously uncharted role for SNPs in the pathogenesis of PD.
引用
收藏
页码:115 / 117
页数:2
相关论文
共 50 条
  • [41] CRISPR/Cas9 in epigenetics studies of health and disease
    Sar, Pranati
    Dalai, Sarat
    REPROGRAMMING THE GENOME: CRISPR-CAS-BASED HUMAN DISEASE THERAPY, 2021, 181 : 309 - 343
  • [42] Generation of Gene-Knockout Mongolian Gerbils via CRISPR/Cas9 System
    Wang, Yan
    Zhao, Peikun
    Song, Zidai
    Du, Xiaoyan
    Huo, Xueyun
    Lu, Jing
    Liu, Xin
    Lv, Jianyi
    Li, Changlong
    Guo, Meng
    Chen, Zhenwen
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2020, 8 (08):
  • [43] Abrogation of Marek’s disease virus replication using CRISPR/Cas9
    Ibrahim T. Hagag
    Darren J. Wight
    Denise Bartsch
    Hicham Sid
    Ingo Jordan
    Luca D. Bertzbach
    Benjamin Schusser
    Benedikt B. Kaufer
    Scientific Reports, 10
  • [44] Abrogation of Marek's disease virus replication using CRISPR/Cas9
    Hagag, Ibrahim T.
    Wight, Darren J.
    Bartsch, Denise
    Sid, Hicham
    Jordan, Ingo
    Bertzbach, Luca D.
    Schusser, Benjamin
    Kaufer, Benedikt B.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [45] In vivo neuronal gene editing via CRISPR–Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer’s disease
    Hanseul Park
    Jungju Oh
    Gayong Shim
    Byounggook Cho
    Yujung Chang
    Siyoung Kim
    Soonbong Baek
    Hongwon Kim
    Jeain Shin
    Hwan Choi
    Junsang Yoo
    Junyeop Kim
    Won Jun
    Minhyung Lee
    Christopher J Lengner
    Yu-Kyoung Oh
    Jongpil Kim
    Nature Neuroscience, 2019, 22 : 524 - 528
  • [46] Treatment of Herpetic Keratitis with CRISPR/Cas9 Gene Editing in a Rabbit Disease Model
    Shen, Shen
    Owens, Christopher M.
    Chao, Hoson
    Yudkoff, Clifford J.
    Diner, Benjamin
    Fusco, Robert
    Tabbaa, Diana
    Giannoukos, Georgia
    Stefanidakis, Michael
    Friedland, Ari
    Baciu, Peter
    Neumann, Donna
    Albright, Charlie
    MOLECULAR THERAPY, 2018, 26 (05) : 128 - 128
  • [47] Insights into maize genome editing via CRISPR/Cas9
    Agarwal, Astha
    Yadava, Pranjal
    Kumar, Krishan
    Singh, Ishwar
    Kaul, Tanushri
    Pattanayak, Arunava
    Agrawal, Pawan Kumar
    PHYSIOLOGY AND MOLECULAR BIOLOGY OF PLANTS, 2018, 24 (02) : 175 - 183
  • [48] Efficient and Heritable Gene Targeting in Tilapia by CRISPR/Cas9
    Li, Minghui
    Yang, Huihui
    Zhao, Jiue
    Fang, Lingling
    Shi, Hongjuan
    Li, Mengru
    Sun, Yunlv
    Zhang, Xianbo
    Jiang, Dongneng
    Zhou, Linyan
    Wang, Deshou
    GENETICS, 2014, 197 (02) : 591 - U219
  • [49] CRISPR/Cas9 gene editing for genodermatoses: progress and perspectives
    Naso, Gaetano
    Petrova, Anastasia
    EMERGING TOPICS IN LIFE SCIENCES, 2019, 3 (03) : 313 - 326
  • [50] CRISPR/CAS9 GENE EDITING TO BLOCK MALARIA TRANSMISSION
    Simoes, Maria
    Dong, Yuemei
    Dimopoulos, George
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 262 - 262